Genetic rescue of Cdk4 null mice restores pancreatic β-cell proliferation but not homeostatic cell number
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Lack of Cdk4 expression in mice leads to insulin-deficient diabetes and female infertility owing to a reduced number of pancreatic beta cells and prolactin-producing pituitary lactotrophs, respectively. Cdk4 null mice display also reduced body and organ size. Here, we show that Cdk4 is essential for the postnatal proliferation of pancreatic beta cells but not for embryonic neogenesis from ductal epithelial cells. Re-expression of endogenous Cdk4 in beta cells and in the pituitary gland of Cdk4 null mice restores cell proliferation and results in fertile and normoglycemic animals, thus, demonstrating that the proliferation defects in these cellular populations are cell autonomous because of the lack of Cdk4 expression. However, these mice remain small in size, indicating that this phenotype is not because of pancreatic- or pituitary-mediated endocrine defects. This phenotype is a consequence of reduced cell numbers rather than reduced cell size. Thus, mammalian Cdk4 is not only involved in controlling proliferation of specific cell types but may play a wider role in establishing homeostatic cell numbers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, when cell cycle arrest is induced specifically in β-cells by overexpression of p27 [24] or by deletion of Cdk4 postnatally, β-cell mass decreases or fails to expand, which would not be the case if neogenesis or transdifferentiation were major sources of new β-cells [25,26].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [26]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182 · cited 1×
“In mammals, control of cell proliferation in response to growth-stimulatory signals is mediated by a complex molecular machinery that must regulate exit from quiescence as well as progression through G1 into the S phase (Pardee, 1989).”
BackgroundTo cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Self-citationPostic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302 · cited 2×
“To this end, we crossed Cdk4n/n mice with a transgenic strain that expresses the Cre recombinase under the control of the rat insulin promoter (Rip-Cre mice) (Postic et al., 1999).”
BackgroundSelf-citationA p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Kulkarni, R. N., Brüning, J. C., Winnay, J. N., Postic, C., Magnuson, M. A., & Kahn, C. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80546-2 · Cited by 1,148
Self-citationLundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,067
Research works printed but not linked: 1
- Reed SI . (1997). Cancer Survey, 29, 7–23. · doi:10.1016/s1076-0512(97)00193-3
Cited by
Items 101–143 of 143
The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases
Liang, X.-B., Dai, Z.-C., Zou, R., Tang, J., & Yao, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713558 · Cited by 5
Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics
Malumbres, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_10 · Cited by 5
Self-citationPancreatic β-Cell Senescence: Mechanisms and Association with Diabetes
Ahmed, S. M., Elshenawy, S. E., Sedky, S., Elmehrath, A. O., & El‐Badri, N. (2021) · European Medical Journal · doi:10.33590/emj/20-00128 · Cited by 5
Mammalian Development and Cancer: A Brief History of Mice Lacking D-Type Cyclins or CDK4/CDK6
Kalaszczyńska, I., & Ciemerych, M. A. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_2 · Cited by 4
Regulation of Cell Cycle During Liver Regeneration
Nevzorova, Y. A., & Trautwein, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420128-6.00011-7 · Cited by 4
CDK4, cible thérapeutique des adénocarcinomes pulmonaires porteurs d’une mutation de l’oncogèneKRAS
Dubus, P. R. (2010) · médecine/sciences · doi:10.1051/medsci/201026121023 · Cited by 4
Self-citationBarquissau, V., Zanou, N., Geller, S., Castillo‐Armengol, J., Marzetta, F., Huber, K., Ziegler, D. V., López‐Mejía, I. C., Fernandez, J. B., Roger, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.03.482783 · Cited by 3
CDK4 loss-of-function mutations cause microcephaly and short stature
Schlie, A. V., Leitch, A., Arismendi, M. I., Stok, C., Leal, A. D. C., Parry, D. A., Lerário, A. M., Harley, M. E., Freire, B. L., Carroll, P. L., et al. (2025) · Genes & Development · doi:10.1101/gad.352311.124 · Cited by 3
Preclinical Models for Cell Cycle-Targeted Therapies
Malumbres, M. (2006) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-5133-3_13 · Cited by 2
Self-citationDubus, P. R., Malumbres, M., & Ortega, S. (2006) · Enzyme inhibitors series/CRC enzyme inhibitors series · doi:10.1201/9781420005400.ch3 · Cited by 1
Self-citationJetton, T. L., Gupta, D., & Peshavaria, M. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-256-8_3 · Cited by 1
INDUCTION OF CDC25B FOLLOWING DNA DAMAGE: IMPLICATIONS FOR CELL CYCLE RESUMPTION AND TUMORIGENESIS
Bansal, P. (2007) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Understanding the roles of Non-homologous end joining and p53 after DNA damage
Tavana, O. (2012) · Digital Commons-TMC (Texas Medical Center) · Cited by 1
Development of fluorescent biosensors and inhibitors to probe and target CDK4/cyclin D in melanoma
Prével, C. (2015) · theses.fr (ABES) · doi:10.70675/acc45705z7b44z4fe2zbc0ez866d13764616 · Cited by 1
Cell Cycle Regulation in Human Pancreatic Beta Cells
Fiaschi‐Taesch, N., Harb, G., Karsiloglu, E., Takane, K. K., & Stewart, A. F. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-366-4_3
Salpeter, S. J., & Dor, Y. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_13
The role of FOXM1 in pancreatic beta cell mass regeneration and expansion
Misfeldt, A. A. (2008)
Regulation of the G1-S transition by cyclin-dependent kinase inhibitors
Ramsey, M. R. (2007) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/sfvt-t742
Targeting CDK4 and CDK6 in hormone-dependent cancers
Bobbitt, J. R., & Keri, R. A. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.10.006
Adam, N. M. (2006) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Updating the Mammalian Cell Cycle: The Role of Interphase Cdks in Tissue Homeostasis and Cancer
Barbacid, M. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-16602-0_1
Self-citationHu, W., & Bernhagen, J. (2013) · RWTH Publications (RWTH Aachen)
Implication de la kinase CDK4 dans la biologie de l'adipocyte
Lagarrigue, S. (2013) · theses.fr (ABES) · doi:10.70675/f96ec904z75d2z49d1za9c5z699741858808
Ciblage thérapeutique de la protéine CDK6 dans les leucémies aiguës myéloïdes
Brault, L. M. (2022) · theses.fr (ABES) · doi:10.70675/26bca708z5a9az4d80z85bfz9159b330b1e8
Analysis of a new transgenic mouse model with ß-cell-specific overexpression of human betacellulin
Grzech, M. (2010) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.11347
Analysis of a new transgenic mouse model with β-cell-specific overexpression of human betacellulin
München, L.-M.-U., & Wolf, E. (2009)
Investigation of mechanisms regulating cell proliferation in the zebrafish developmental program
Amin, S. R. (2010) · Rice Research Repository (Rice University)
Diverse functions of caspases in beta cell homeostasis and type 1 and type 2 diabetes models
Liadis, N. (2007) · TSpace (University of Toronto)
Lysosomes at the crossroads between CDK4 and mTOR pathway
Martínez-Carreres, L. (2019) · IRIS
Etude des modifications post-traductionnelles de la protéine ATF7
Schaeffer, É. (2014) · theses.fr (ABES) · doi:10.70675/7ffb5d1azba7az4b47za3c2zc9785aba9213
The Generation of Fully Functional β-Cells by Proliferation: Lessons From Pregnancy and HNF4α
Rieck, S. (2011) · Scholarly Commons (University of Pennsylvania)
Régulation de la division asymétrique chez C. elegans
Rabilotta, A. (2015) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/30562
Agrawal, T. (2013) · ScholarlyCommons (University of Pennsylvania)
Cerqueira, A. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Zhao, F. (2012) · TSpace (University of Toronto)
Die Cyclin-abhängigen Kinasen 4 und 6 als Zielproteine für die Therapie und Bildgebung von Tumoren
Graf, F. (2010) · Qucosa (Saxon State and University Library Dresden)
Regulación del ciclo celular y el desarrollo de tumores in vivo por inhibidores INK4 y Cip/Kip
Quereda, V. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Martín, J., Hunt, S. L., Dubus, P., Sotillo, R., Néhmé-Pélluard, F., Magnuson, M. A., Parlow, A. F., Malumbres, M., Ortega, S., & Barbacid, M.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Université de Bordeaux (FR)
- Vanderbilt University (US)
- Harbor–UCLA Medical Center (US)
- Corresponding author
- Ortega, Sagrario
- Venue
- Oncogene
- Published
- 2003-08-14
- Volume
- 22
- Issue
- 34
- Pages
- 5261-5269
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2030209853
- Cited by
- 122
- References
- 30
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 4 · 2012: 5
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Comunidad de Madrid
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- CDK4, pancreatic beta cells, beta-cell proliferation, genetic rescue, diabetes mellitus, infertility, lactotrophs, pituitary gland, insulin deficiency
- MeSH terms
- Animals, Body Constitution, Cell Division, Islets of Langerhans, Mutation, Phenotype, Proto-Oncogene Proteins, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.